Parvez Singh Slathia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Parvez Singh Slathia has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Preeti Sharma
School of Biotechnology, Shri Mata Vaishno Devi University, Katra, J&K 182320, India
8 shared publicationsNeelu Raina
School of Biotechnology, Shri Mata Vaishno Devi University, Katra, J&K-182320, India
7 shared publicationsDeepali Bhagat
School of Biotechnology, Shri Mata Vaishno Devi University
5 shared publications- Preeti Sharma
School of Biotechnology, Shri Mata Vaishno Devi University, Katra, J&K-182320, India
4 shared publications P. Sharma
3 shared publicationsMeenu Katoch
Microbial Biotechnology Division, CSIR - Indian Institute of Integrative Medicine, Canal Road, Jammu, 180001, India
2 shared publications
Latest Publications
- 8 September 2026
- Published by Elsevier in Human Immunology
- Vol. 87 (11) , 112066
Computational design, structural modeling and immune evaluation of an amastin-based multi-epitope vaccine candidate against leishmaniasis
- 8 September 2026
- Published by Elsevier in Human Immunology
- Vol. 87 (11) , 112066
Computational design, structural modeling and immune evaluation of an amastin-based multi-epitope vaccine candidate against leishmaniasis
- 1 November 2020
- Published by Elsevier in Bioresource Technology
- Vol. 316, 123850
Bioprocessing of cultivated Chlorella pyrenoidosa on poultry excreta leachate to enhance algal biomolecule profile for resource recovery
- 1 November 2020
- Published by Elsevier in Bioresource Technology
- Vol. 316, 123850
Bioprocessing of cultivated Chlorella pyrenoidosa on poultry excreta leachate to enhance algal biomolecule profile for resource recovery
- 27 October 2020
- Published by Elsevier in Biomass and Bioenergy
- Vol. 143, 105819
Experimental optimization of thermochemical pretreatment of sal (Shorea robusta) sawdust by Central Composite Design study for bioethanol production by co-fermentation using Saccharomyces cerevisiae (MTCC-36) and Pichia stipitis (NCIM-3498)
- 27 October 2020
- Published by Elsevier in Biomass and Bioenergy
- Vol. 143, 105819
Experimental optimization of thermochemical pretreatment of sal (Shorea robusta) sawdust by Central Composite Design study for bioethanol production by co-fermentation using Saccharomyces cerevisiae (MTCC-36) and Pichia stipitis (NCIM-3498)
- 10 October 2020
- Published by Springer Nature
- p. 245-277
In Silico Designing of Vaccines: Methods, Tools, and Their Limitations
In the post genomic era, the finding of new therapeutic targets has hugely been accelerated by the use of bioinformatics tools. The availability of genome sequences of pathogenic microbes has led to an increased finding of genes and proteins that could be potential targets for drug or vaccine design. The tools made available by bioinformatics have played a central role in the analysis of the genome and protein sequences for finding immunogenic proteins among the repertoire possessed by the organisms. The methods for prediction of immunogenicity are automated, and the whole proteome can be analyzed to find the top candidates that could have immunity inducing properties. Not only finding of immunogenic proteins has been achieved, but the mapping of the individual epitopes is also being done. The availability of methods for finding T and B cell epitopes can lead to the design of epitope-based vaccines. The description of different bioinformatics tools that are available for determining the immunogenic properties, finding of T and B cell epitopes, and in silico tools that are used in vaccine design is given in here. An account of epitope-based vaccine design employing bioinformatics methods reported in the literature is discussed. There are many shortcomings associated with these methods, which are discussed in the chapter. As is the case with other bioinformatics methods, there exist issues of prediction accuracy. Achievement of higher accuracy in predictions and their translation into in vivo/in vitro conditions still requires improvement. The chapter intends to provide the list of freely accessible software for epitope prediction and vaccine design with their merits/demerits and also throwing light on their applicability in vaccine research.
- 10 October 2020
- Published by Springer Nature
- p. 245-277
In Silico Designing of Vaccines: Methods, Tools, and Their Limitations
In the post genomic era, the finding of new therapeutic targets has hugely been accelerated by the use of bioinformatics tools. The availability of genome sequences of pathogenic microbes has led to an increased finding of genes and proteins that could be potential targets for drug or vaccine design. The tools made available by bioinformatics have played a central role in the analysis of the genome and protein sequences for finding immunogenic proteins among the repertoire possessed by the organisms. The methods for prediction of immunogenicity are automated, and the whole proteome can be analyzed to find the top candidates that could have immunity inducing properties. Not only finding of immunogenic proteins has been achieved, but the mapping of the individual epitopes is also being done. The availability of methods for finding T and B cell epitopes can lead to the design of epitope-based vaccines. The description of different bioinformatics tools that are available for determining the immunogenic properties, finding of T and B cell epitopes, and in silico tools that are used in vaccine design is given in here. An account of epitope-based vaccine design employing bioinformatics methods reported in the literature is discussed. There are many shortcomings associated with these methods, which are discussed in the chapter. As is the case with other bioinformatics methods, there exist issues of prediction accuracy. Achievement of higher accuracy in predictions and their translation into in vivo/in vitro conditions still requires improvement. The chapter intends to provide the list of freely accessible software for epitope prediction and vaccine design with their merits/demerits and also throwing light on their applicability in vaccine research.
- 28 August 2020
- Published by Springer Nature in Biomass Conversion and Biorefinery
- Vol. 12 (11) , 5175-5195
Response surface methodology (RSM) for optimization of thermochemical pretreatment method and enzymatic hydrolysis of deodar sawdust (DS) for bioethanol production using separate hydrolysis and co-fermentation (SHCF)
- 28 August 2020
- Published by Springer Nature in Biomass Conversion and Biorefinery
- Vol. 12 (11) , 5175-5195
Response surface methodology (RSM) for optimization of thermochemical pretreatment method and enzymatic hydrolysis of deodar sawdust (DS) for bioethanol production using separate hydrolysis and co-fermentation (SHCF)
- Open Access
- 15 April 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Prediction of T and B Cell Epitopes in the Proteome of SARS-CoV-2 for Potential Use in Diagnostics and Vaccine Design
The world is currently battling the Covid-19 pandemic for which there is no therapy available. Prophylactic measures like vaccines can effectively thwart the disease burden. The current methods of detection are PCR based and require skilled manpower to operate. The availability of cheap and ready to use diagnostics like serological methods can ease the detection of SARS-CoV-2 virus. In the current study, immunoinformatics tools have been used to predict T and B cell epitopes present in all the proteins of this virus. NetMHCPan, NetCTL and NetMHCII servers were used for T cell epitope prediction while BepiPred and ABCPred were used for B cell epitope prediction. Population coverage analysis for T cell epitopes revealed that these could provide protection to the people throughout world. The T cell epitopes can exclusively used for vaccine design whereas B cell epitopes can be used for both vaccine design and developing diagnostic kits.
- 15 April 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPrediction of T and B Cell Epitopes in the Proteome of SARS-CoV-2 for Potential Use in Diagnostics and Vaccine Design
The world is currently battling the Covid-19 pandemic for which there is no therapy available. Prophylactic measures like vaccines can effectively thwart the disease burden. The current methods of detection are PCR based and require skilled manpower to operate. The availability of cheap and ready to use diagnostics like serological methods can ease the detection of SARS-CoV-2 virus. In the current study, immunoinformatics tools have been used to predict T and B cell epitopes present in all the proteins of this virus. NetMHCPan, NetCTL and NetMHCII servers were used for T cell epitope prediction while BepiPred and ABCPred were used for B cell epitope prediction. Population coverage analysis for T cell epitopes revealed that these could provide protection to the people throughout world. The T cell epitopes can exclusively used for vaccine design whereas B cell epitopes can be used for both vaccine design and developing diagnostic kits.
- 23 February 2020
- Published by Springer Nature
- p. 271-297
Efficiency Enhancement of Renewable Energy Systems Using Nanotechnology
- 23 February 2020
- Published by Springer Nature
- p. 271-297
Efficiency Enhancement of Renewable Energy Systems Using Nanotechnology
- Open Access
- 5 February 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Probiotic properties of a phytase producing Pediococcus acidilactici strain SMVDUDB2 isolated from traditional fermented cheese product, Kalarei
The nutritional challenge faced by the monogastric animals due to the chelation effects of phytic acid, fuel the research on bioprospecting of probiotics for phytase production. Pediococcus acidilactici SMVDUDB2 isolated from Kalarei, exhibited extracellular phytase activity of 5.583 U/mL after statistical optimization of fermentation conditions viz. peptone (1.27%); temperature (37 °C); pH (6.26) and maltose (1.43%). The phytase enzyme possessed optimum pH and temperature of 5.5 and 37 °C, respectively and was thermostable at 60 °C. The enzyme was purified 6.42 fold with a specific activity of 245.12 U/mg with hydrophobic interaction chromatography. The purified enzyme had Km and Vmax values of 0.385 mM and 4.965 μmol/min respectively, with sodium phytate as substrate. The strain depicted more than 80% survival rate at low pH (pH 2.0, 3.0), high bile salt concentration (0.3 and 0.5%), after gastrointestinal transit, highest hydrophobicity affinity with ethyl acetate (33.33 ± 0%), autoaggregation (77.68 ± 0.68%) as well as coaggregation (73.57 ± 0.47%) with Staphylococcus aureus (MTCC 3160). The strain exhibited antimicrobial activity against Bacillus subtilis (MTCC 121), Mycobacterium smegmatis (MTCC 994), Staphylococcus aureus (MTCC 3160), Proteus vulgaris (MTCC 426), Escherichia coli (MTCC 1652) and Lactobacillus rhamnosus (MTCC 1408). The amount of exopolysaccharide produced by the strain was 2 g/L. This strain having the capability of phytate degradation and possessing probiotic traits could find application in food and feed sectors.
- 5 February 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Open AccessProbiotic properties of a phytase producing Pediococcus acidilactici strain SMVDUDB2 isolated from traditional fermented cheese product, Kalarei
The nutritional challenge faced by the monogastric animals due to the chelation effects of phytic acid, fuel the research on bioprospecting of probiotics for phytase production. Pediococcus acidilactici SMVDUDB2 isolated from Kalarei, exhibited extracellular phytase activity of 5.583 U/mL after statistical optimization of fermentation conditions viz. peptone (1.27%); temperature (37 °C); pH (6.26) and maltose (1.43%). The phytase enzyme possessed optimum pH and temperature of 5.5 and 37 °C, respectively and was thermostable at 60 °C. The enzyme was purified 6.42 fold with a specific activity of 245.12 U/mg with hydrophobic interaction chromatography. The purified enzyme had Km and Vmax values of 0.385 mM and 4.965 μmol/min respectively, with sodium phytate as substrate. The strain depicted more than 80% survival rate at low pH (pH 2.0, 3.0), high bile salt concentration (0.3 and 0.5%), after gastrointestinal transit, highest hydrophobicity affinity with ethyl acetate (33.33 ± 0%), autoaggregation (77.68 ± 0.68%) as well as coaggregation (73.57 ± 0.47%) with Staphylococcus aureus (MTCC 3160). The strain exhibited antimicrobial activity against Bacillus subtilis (MTCC 121), Mycobacterium smegmatis (MTCC 994), Staphylococcus aureus (MTCC 3160), Proteus vulgaris (MTCC 426), Escherichia coli (MTCC 1652) and Lactobacillus rhamnosus (MTCC 1408). The amount of exopolysaccharide produced by the strain was 2 g/L. This strain having the capability of phytate degradation and possessing probiotic traits could find application in food and feed sectors.
- 28 June 2019
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 65, 238-245
A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines
- 28 June 2019
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 65, 238-245
A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines